Back to All

Diaceutics Global Data Repository leads the way to smarter data-enabled precision medicine at ASCO 2020

15 May, 2020

Diaceutics Global Data Repository leads the way to smarter data-enabled precision medicine at ASCO 2020 Diaceutics will demonstrate the valuable role of real-world testing data in improving precision medicine at the 2020 American Society of Clinical Oncology (ASCO) Annual Meeting, which will take place virtually from May 29-31. This year, Diaceutics, a precision diagnostics commercialization company for the global pharmaceutical industry, will present a poster and 4 abstracts. Each study features data analyzed from the Diaceutics proprietary Global Data Lake, which holds more than 227 million real-world patient records from 35 countries. The poster and abstracts can be accessed here:

  • Poster #7528: Stability of rare TP53 co-mutations in AML patients. Kenneth J Bloom MD; Adam Idica PhD, Dave Smart PhD, Wendy L Allen PhD, Enya Scanlon MRes, Jordan Clark MPhil (Publication on May 29th, 2020)
  • Abstract # e18052: HRD in Ovarian Cancer – Defined Today, Evolving for the Future. Markus Eckstein MD, Kenneth J Bloom MD, Peter V Riccelli PhD, Frank Policht BA, Derry Mae Keeling BSc, Jordan Clark MPhil
  • Abstract # e13652: Economic burden of not testing for FLT3 to treat Acute Myeloid Leukemia. Raymond Henderson PhD, Dave Smart PhD, Declan French PhD, Jordan Clark MPhil, Kenneth Bloom MD, Derek Hosty BTech, Mark Lawler PhD, FRCPath
  • Abstract #e15574: Use of real-world clinical lab data to reveal Asian NTRK fusion test availability patterns. Markus Eckstein MD, Kenneth J Bloom MD, Susanne Munksted MSc, Marieke Hoefsmit MSc, Jordan Clark MPhil
  • Abstract # e15667: Drugging the Undruggable: A Market Readiness Analysis for KRAS-G12C. Fotios Loupakis MD, PhD, Kenneth J. Bloom MD, Wendy L Allen PhD, Enya E Scanlon MRes, Isabel Stacey MMath, Derry Mae Keeling BSc, Nital Patel MBA, Jordan Clark MPhil

About Diaceutics

At Diaceutics we believe that every patient should get the precision medicine they deserve. We are a data analytics and end-to-end services provider enabled by DXRX - the world’s first Network solution for the development and commercialization of precision medicine diagnostics. 

Diaceutics has worked on every precision medicine brought to market and provides services to 36 of the world’s leading pharmaceutical companies. We have built the world’s largest repository of diagnostic testing data with a growing network of 2500 labs in 51 countries.

Public Relations & Investor Relations advisers

Alma PR
71-73 Carter Lane

Tel: +44 (0)20 3405 0205 or [email protected]

Caroline Forde
Robyn Fisher
Kieran Breheny